Document is current
Any future updates will be listed below
-
Authors
Durez, Patrick http://orcid.org/0000-0002-7156-2356
Westhovens, Rene
Baeke, Femke
Elbez, Yedid
Robert, Sofie
Ahmad, Harris A.
- License Information
-
More Information
Article History
Received: 20 August 2021
Accepted: 9 February 2022
First Online: 14 April 2022
Declarations
:
: The global study was conducted in accordance with the Declaration of Helsinki, International Conference on Harmonization's Guideline for Good Clinical Practice and Good Epidemiological Practice, and with the approval of the Central Ethics Committee (UZ Leuven, October 2005). All patients provided written informed consent. The data used in this study were anonymised before its use. No additional administrative permission was required to access the raw data in this study.
: Not applicable.
: PD received speaker fees from Bristol-Myers Squibb, Eli Lilly, Sanofi and Celltrion. RW was a consultant for Celltrion, Galapagos-Gilead. YE was employee of a CRO company (Excelya) contracting with Bristol-Myers Squibb. SR, FB, and HA are employees. SR and FB are shareholders of Bristol-Myers Squibb.
